Lataa...
The Immune Checkpoint PD-1 in Natural Killer Cells: Expression, Function and Targeting in Tumour Immunotherapy
In the last years, immunotherapy with antibodies against programmed cell death protein 1 (PD-1) and programmed death-ligand 1 (PD-L1) has shown remarkable efficacy in the treatment of different types of tumours, representing a true revolution in oncology. While its efficacy has initially been attrib...
Tallennettuna:
Päätekijät: | , , , , , |
---|---|
Aineistotyyppi: | Artigo |
Kieli: | Inglês |
Julkaistu: |
MDPI AG
2020-11-01
|
Sarja: | Cancers |
Aiheet: | |
Linkit: | https://www.mdpi.com/2072-6694/12/11/3285 |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|